July 1, 2007Expert Review of Cardiovascular Therapy
Percutaneous coronary intervention and the no-reflow phenomenon
Population
Patients undergoing percutaneous coronary intervention, particularly saphenous vein graft intervention…
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Refractory no-reflow marks high-risk PCI cases; hypothesis-generating for prevention strategies, should not yet change practice.
Structured PICO
P
Population
Patients undergoing percutaneous coronary intervention (PCI), particularly saphenous vein graft intervention, rotational atherectomy, and primary PCI for acute ST-elevation myocardial infarction
I
Intervention
Prevention and management strategies for no-reflow (antiplatelet agents, vasodilators, and/or mechanical devices)
Refractory no-reflow during PCI is a severe complication associated with increased 30-day mortality, emphasizing the importance of preventive strategies and pharmacologic management.
Cite This Study
Gaal et al. (2007) studied this question.